Cross Country Healthcare, Inc. CCRN R2K

Healthcare · Medical Care Facilities · United States

https://www.crosscountry.com

Cross Country Healthcare, Inc. provides talent management services for healthcare clients in the United States. The company operates in two segments: Nurse and Allied Staffing, and Physician Staffing. The Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel nurse and allied professionals, per diem, and healthcare leaders within nursing, allied, human resources, and finance; vendor neutral and managed services programs; and education healthcare, caregiver services, and outsourcing services. This segment offers staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term assignments, as well as workforce solutions, including MSP, VMS, RPO, project management, and other outsourcing and consultative services. It also provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. The company serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, correctional facilities, PACE programs, physician practice groups, and other healthcare providers. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments. This segment serves various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.

Market & Price

Market Cap

$405.90M

Current Price

$13.09

High / Low (52W)

$14.25 / $7.53

Beta

0.36

Valuation

Stock P/E

Industry PE

23.65

Forward P/E

46.51

PEG Ratio

11.38

Book Value

$10.01

Price to Book

1.31

P/S

0.41

EV/EBITDA

22.65

Dividend Yield

Profitability & Returns

ROCE

-21.90%

ROE

-26.98%

ROA

-0.10%

Profit Margin

-9.84%

Op Margin

-0.81%

EPS (Latest Qtr)

$-0.14

EPS (TTM)

$-3.05

Balance Sheet & Liquidity

Debt/Equity

0.65

Quick Ratio

3.20

Current Ratio

3.29

Debt

$2.04M

Total Assets

$448.95M

Current Assets

$293.59M

Working Capital

$215.83M

Ownership

Promoter Holding

7.71%

Chg in Prom Hold

FII / Inst Holding

95.06%

Chg in FII Hold

Financial Snapshot

Enterprise Value

$319.69M

Total Revenue (TTM)

$1.00B

EBITDA

$14.11M

Free Cash Flow

$47.09M

Operating Cash Flow

$47.34M

Shares Outstanding

31.01M

Gross Margin

20.21%

Payout Ratio

0.00%

Growth (CAGR)

Revenue 5Y

-27.82%

Profit 5Y

-50.33%

Revenue (YoY)

-17.80%

Earnings (YoY)

PROS

Generates positive free cash flow.
In a confirmed uptrend (50-DMA above 200-DMA).

CONS

Revenue declined at -27.8% CAGR over 5 years.
Earnings shrank at -50.3% CAGR over 5 years.
RSI at 76 suggests overbought conditions.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	CCRN Cross Country Healthcare, Inc. R2K	13.09	-	$405.90M	-	-21.90%	-26.98%	-27.82%	-50.33%
2	LLY Eli Lilly and Company SPX	1,105.00	39.21	$985.37B	0.63%	38.44%	107.46%	31.69%	48.96%
3	JNJ Johnson & Johnson SPX	225.33	26.11	$542.42B	2.38%	23.13%	26.42%	5.60%	14.32%
4	UNH UnitedHealth Group Incorporated SPX	380.31	28.66	$345.38B	2.32%	9.60%	12.18%	11.35%	-15.69%
5	MRK Merck & Co., Inc. SPX	118.72	33.44	$293.22B	2.86%	20.66%	18.94%	3.12%	7.93%
6	TMO Thermo Fisher Scientific Inc. SPX	492.51	27.11	$183.03B	0.38%	9.17%	13.52%	-0.27%	-1.19%
7	AMGN Amgen Inc. NDXSPX	336.79	23.42	$181.77B	2.99%	18.02%	101.32%	11.77%	5.58%
8	GILD Gilead Sciences, Inc. NDXSPX	134.43	18.29	$166.90B	2.44%	22.92%	43.36%	2.57%	22.83%
9	ISRG Intuitive Surgical, Inc. NDXSPXAI	424.64	51.53	$150.39B	-	15.96%	17.23%	17.39%	29.26%

Quarterly Results

Figures in USD.

Metric	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	-	-	-	-	210.29M	204.57M	200.72M	200.91M	195.17M	202.76M	209.20M	215.10M	210.06M	216.78M	193.97M	215.61M	329.24M	331.83M	374.90M	640.68M	788.73M	753.56M	636.10M	628.22M	622.71M	540.70M	442.29M	414.04M	379.17M	339.77M	315.12M	-	293.41M	274.07M	250.05M	236.76M	241.06M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	234.75M	218.07M	199.12M	188.78M	193.47M
Gross Profit	54.85M	58.21M	57.63M	53.27M	56.53M	60.48M	58.30M	53.75M	53.69M	51.56M	50.56M	48.25M	51.59M	51.01M	53.16M	49.60M	50.73M	48.00M	54.39M	71.47M	72.59M	83.79M	147.15M	174.79M	170.41M	143.54M	138.94M	139.42M	123.14M	97.36M	90.49M	77.30M	70.81M	64.16M	-	58.66M	56.00M	50.93M	47.98M	47.59M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	57.26M	54.15M	50.98M	55.08M	49.48M
Operating Income	-17.02M	9.33M	-	3.25M	6.45M	8.37M	-	4.25M	4.34M	2.65M	-	-2.69M	-15.10M	119.00K	-	-754.00K	-13.69M	-381.00K	-	20.99M	15.90M	26.45M	-	90.63M	78.84M	52.17M	-	43.80M	35.19M	20.30M	-	2.92M	-19.21M	2.85M	-	1.40M	1.85M	-55.00K	-7.10M	-1.89M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4.42M	-1.08M	-993.00K	-66.84M	502.00K
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	543.00K	549.00K	556.00K	568.00K	567.00K
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-899.00K	-5.73M	-5.64M	-71.25M	-3.73M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-409.00K	930.00K	-863.00K	11.68M	532.00K
Net Income	-17.24M	14.07M	-7.88M	-2.01M	4.85M	6.72M	27.95M	1.64M	1.54M	-441.00K	-19.69M	-1.77M	-51.67M	-3.13M	-1.14M	-2.09M	-14.15M	-1.33M	4.61M	19.45M	11.55M	23.43M	77.57M	61.98M	52.89M	34.79M	38.79M	29.44M	21.34M	12.81M	9.04M	2.69M	-16.05M	2.56M	-	-490.00K	-6.66M	-4.77M	-82.93M	-4.27M
Diluted EPS	-0.54	0.22	-0.24	-0.08	0.13	0.19	0.77	0.05	0.04	-0.01	-0.55	-0.05	-1.44	-0.09	-0.03	-0.06	-0.39	-0.04	0.13	0.53	0.31	0.62	2.07	1.63	1.40	0.93	1.05	0.81	0.60	0.36	0.26	0.08	-0.47	0.08	-	-0.02	-0.20	-0.15	-2.56	-0.14

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	-	-	-	-	-	-	-	-	865.05M	816.48M	822.22M	836.42M	-	2.80B	2.02B	1.34B	1.05B
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	2.18B	1.57B	1.07B	840.72M
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	624.46M	450.41M	274.25M	213.57M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	336.79M	318.68M	251.58M	217.47M
Operating Income	17.70M	-3.81M	5.91M	-24.52M	-8.02M	-10.47M	20.57M	6.18M	11.75M	-12.88M	-15.71M	-9.16M	-	287.67M	131.73M	22.68M	-3.90M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	280.06M	129.34M	3.99M	-64.50M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	14.39M	8.09M	2.19M	2.22M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	253.10M	102.89M	-16.40M	-83.51M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	67.11M	30.26M	-1.84M	11.34M
Net Income	6.69M	-2.77M	4.10M	-42.22M	-51.97M	-31.78M	4.42M	7.97M	37.51M	-16.95M	-57.71M	-12.96M	-	185.98M	72.63M	-14.56M	-94.85M
Diluted EPS	0.22	-0.09	0.13	-1.37	-1.68	-1.02	0.14	0.15	1.01	-0.48	-1.61	-0.36	-	5.02	2.05	-0.44	-2.93

Compounded Sales Growth

5 Years:	-27.82%
1 Year:	-17.80%

Compounded Profit Growth

5 Years:	-50.33%
1 Year:	-

Stock Price Performance

1 Year:	-0.68%
6 Months:	+20.31%
3 Months:	+50.46%
1 Month:	+27.46%

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	343.66M	347.94M	305.92M	248.25M	325.13M	365.60M	388.38M	467.69M	427.00M	382.37M	356.97M	-	947.84M	681.06M	589.25M	448.95M
Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	675.67M	416.88M	335.00M	293.59M
Cash & Equivalents	10.17M	6.86M	10.96M	10.65M	10.46M	8.05M	5.00M	2.45M	20.63M	25.54M	16.02M	-	1.60M	-	3.60M	17.09M	81.63M	108.74M
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	-	641.61M	372.35M	223.24M	167.51M
Total Liabilities	-	-	97.65M	98.64M	96.80M	87.58M	194.80M	224.25M	236.58M	229.97M	208.81M	218.87M	202.06M	-	490.62M	213.41M	170.29M	126.13M
Current Liabilities	-	-	35.25M	51.09M	72.59M	44.91M	67.00M	86.05M	97.09M	94.59M	85.39M	85.47M	93.42M	-	271.64M	156.08M	120.40M	77.76M
Long Term Debt	-	-	-	-	-	-	-	-	84.75M	92.26M	77.94M	70.97M	55.83M	176.37M	148.74M	-	-	-
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	157.75M	5.27M	3.87M	2.32M
Total Equity	234.02M	246.07M	246.01M	249.30M	209.12M	160.67M	129.88M	140.85M	151.24M	237.09M	217.53M	162.63M	154.38M	-	457.22M	467.65M	418.96M	322.82M
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	36.30M	34.38M	32.28M	31.72M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	-	31.52M	18.30M	10.15M	8.66M	-4.07M	18.23M	30.14M	45.51M	21.00M	5.54M	27.20M	-	134.05M	248.50M	120.12M	48.25M
Investing Cash Flow	-	-16.20M	-4.20M	175.00K	15.21M	-45.45M	-24.07M	-9.78M	-91.38M	-6.68M	-2.94M	-4.62M	-	-43.87M	-13.78M	-8.71M	-8.16M
Financing Cash Flow	-	-11.19M	-14.24M	-10.58M	-26.06M	46.46M	3.35M	-2.16M	50.76M	-23.77M	-17.60M	-22.01M	-	-87.60M	-221.24M	-46.85M	-13.01M
Capital Expenditure	-2.45M	-2.39M	-4.00M	-2.22M	-1.75M	-4.57M	-2.36M	-6.52M	-5.11M	-4.60M	-2.94M	-4.62M	-	-8.79M	-13.97M	-8.71M	-8.16M
Free Cash Flow	-	29.13M	14.30M	7.93M	6.91M	-8.64M	15.87M	23.62M	40.40M	16.40M	2.60M	22.59M	-	125.26M	234.52M	111.40M	40.09M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-	-	-	-	2.58M	13.48M	64.55M	27.08M
Share Buybacks	-	-	2.23M	374.00K	0	0	-	0	0	5.00M	0	0	0	35.28M	57.65M	37.31M	6.83M

Ratios (Annual)

Figures in %.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	22.3%	22.3%	20.4%	20.3%
Operating Margin %	-	-	-	-	-	-	-	-	1.4%	-1.6%	-1.9%	-1.1%	-	10.3%	6.5%	1.7%	-0.4%
Net Margin %	-	-	-	-	-	-	-	-	4.3%	-2.1%	-7.0%	-1.5%	-	6.6%	3.6%	-1.1%	-9.0%
ROE %	2.7%	-1.1%	1.6%	-20.2%	-32.3%	-24.5%	3.1%	5.3%	15.8%	-7.8%	-35.5%	-8.4%	-	40.7%	15.5%	-3.5%	-29.4%
ROCE %	-	-1.2%	2.0%	-10.5%	-3.9%	-4.1%	7.4%	2.1%	3.1%	-3.8%	-5.3%	-3.5%	-	42.5%	25.1%	4.8%	-1.1%

Shareholding Pattern

Insiders

7.71%

Institutions

95.06%

Public Float

103.00%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Boston Partners	7.87%	2.55M	$33.32M
2	Blackrock Inc.	7.75%	2.51M	$32.82M
3	Dimensional Fund Advisors LP	4.98%	1.61M	$21.07M
4	Vanguard Capital Management LLC	4.24%	1.37M	$17.93M
5	Sio Capital Management, LLC	3.40%	1.10M	$14.38M
6	Quinn Opportunity Partners, LLC	3.17%	1.03M	$13.43M
7	Charles Schwab Investment Management, Inc.	2.94%	952.12K	$12.46M
8	American Century Companies Inc	2.93%	948.13K	$12.41M
9	Oddo BHF Asset Management SAS	2.91%	940.00K	$12.30M
10	Dana Investment Advisors, Inc.	2.89%	933.22K	$12.22M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for CCRN

No recent headlines available.

CCRN · Healthcare